臨床試驗

CHAMPION-AF Clinical Trial

NCT：NCT04394546 · ACTIVE_NOT_RECRUITING

NCT IDNCT04394546

狀態ACTIVE_NOT_RECRUITING

開始日期2020-10-15

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2020-05-19

Last updated2026-09-11

簡要摘要

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。